Invitrogen™ Human ELISA Kit Aggrecan (PG)

Ref.: BL-RE-107654Manufacturer ref.: KAP1461 96 tests
€752.00 excl. VAT

L-ELISA of human aggregate agent (PG) quantifies the Hu aggregate agent (PG) in synovial fluid, serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural human aggregatecan (PG) and...

Accession number
P16112
Dose range
10-250 ng/ml
Sensitivity of the dosage
0.9 ng
Conjugate
HRP
Product type
Kit ELISA
Brand
Invitrogen

L-ELISA of human aggregate agent (PG) quantifies the Hu aggregate agent (PG) in synovial fluid, serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural human aggregatecan (PG) and...

L-ELISA of human aggregate agent (PG) quantifies the Hu aggregate agent (PG) in synovial fluid, serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human aggregate agent (PG). Principle of the L-ELISA (immuno-enzymatic test) solid phase sandwich of human aggrecan (PG) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second enzyme-conjugated antibody (detector), binding to the target on a different epitope from the capture antibody. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.

L-Aggrecan, also known as cartilage specific protein glycane (CSPCP) or chondroitin sulfate protein 1-ACAN-encoded protein, is a protein that is used to control the protein. The coded protein is an integral part of the extracellular matrix in cartilaginous tissue and resists compression in cartilage. The human form of the protein consists of 2316 large amino acids (-250 kDa) and can be expressed in several isoforms due to its alternative splicing. L-Aggrecan has a pin structure on which the chondroitin sulphate and keratane sulphate chains are attached to an expanded protein nucleus. The synthesis and degradation of the aggrecan is studied to determine their role in cartilage deterioration in joint lesions, disease and aging. It contains three interglobulary domains (IGD), G1, G2 and G3 involved in aggregation, binding of l-hyaluronane, cell adhesion, and chondrocyte apoptosis. The joint cartilage fragments of the dagrecane release into the synovial fluid at all stages of human osteoarthritis following cleavage caused by the activity of l'aggrecanase and MMP. The BC-3 and BC-4 antibodies can be used to detect these new d-aggrecanase epitopes (ARGSVXXX) and MMP (XXXVDIPEN), respectively. Order information

Shipping conditions : dry ice

Sensitivity

Sensitivity of the dosage: 0.9 ng.

Measurement range

Dose range: 10-250 ng/ml.

Duration of dosing

Total duration of dosing: 3 h 15 min.

Reproducibility

Coefficient of intra-dose variation 2.1%, inter-dose 5.6%.

Target

Target: Human.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)10384353
Specifications
Accession numberP16112
Dose range10-250 ng/ml
Sensitivity of the dosage0.9 ng
ConjugateHRP
Product typeKit ELISA
Type of sampleSynovial liquid, Serum, Surnatant
Target speciesHuman
For use with (application)Colorimetric detection
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)176
Gene symbol(s)AGC1,AGCAN,CSPG1,CSPGCP,MSK16,SEDK
Incubation time3.25 h
Coefficient of inter-dose variation5.6%
Coefficient of intra-dose variation2.1%
Contents of kits96-well pre-coated plate, Standard, Sample diluent, Incubation buffer, HRP conjugate antibody, Conjugate diluent, Wash pad, Chromogen, Stop solution, isotypic
Marker or dyeHRP
Genetic markerPG
Quantity96 tests
Regulatory statusRUO
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 20 μl; supernatant, 10 μl; synovial liquid, 25 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing3 h 15 min

Origin and customs

Manufacturer ref.KAP1461
Country of originUnited Kingdom
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.